8-KRegulation FD

UNITEDHEALTH GROUP INC 8-K Report, Regulation FD Disclosure (Sep 8, 2026)

Filed September 8, 2026For Securities:UNH

Summary

UnitedHealth Group Incorporated (UNH) has filed an 8-K report on September 8, 2026, primarily to announce upcoming participation in the Wells Fargo 21st Annual Healthcare Conference. Senior leadership will be available to discuss the company's strategy, market positions, recent performance, and outlook for its various end markets during an interview format at the conference on September 9, 2026. This provides investors with an opportunity for direct engagement and insight into the company's forward-looking perspectives. The company will also be providing a live audio webcast of the presentation, accessible via the Investor Relations section of its website. Investors should note that the information disclosed under Item 7.01 of this 8-K is not considered 'filed' for regulatory purposes under Section 18 of the Securities Exchange Act of 1934, nor is it incorporated by reference into other SEC filings, unless specifically stated otherwise. This filing serves as a pre-announcement of management's participation and the topics to be covered.

Key Highlights

  • 1UnitedHealth Group (UNH) senior leaders to participate in an interview at the Wells Fargo 21st Annual Healthcare Conference.
  • 2The conference participation is scheduled for September 9, 2026.
  • 3Topics for discussion will include company strategy, market positions, recent results, and end market expectations.
  • 4A live audio webcast of the presentation will be available on the company's Investor Relations website.
  • 5This 8-K filing is for Regulation FD disclosure purposes regarding the upcoming conference.
  • 6Information disclosed under Item 7.01 is not considered 'filed' for Section 18 purposes unless expressly incorporated by reference.

Frequently Asked Questions

Senior leaders from UnitedHealth Group will be responding to questions in an interview format at the Wells Fargo 21st Annual Healthcare Conference on Wednesday, September 9, 2026, beginning at 8:00 a.m., Eastern Time.

The discussion will cover the Company's strategy, market positions, recent results, and expectations for its end markets.

A live audio webcast of the presentation will be made available through the Investor Relations page of UnitedHealth Group's website at www.unitedhealthgroup.com.

No, the information in Item 7.01 of this 8-K filing is not deemed 'filed' for purposes of Section 18 of the Securities Exchange Act of 1934, nor is it incorporated by reference in other Company filings under the Securities Act of 1933 or the Securities Exchange Act of 1934, except as shall be expressly set forth by specific reference in such filing.